Daniela Buonvicino

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Tumor expression of CGRP confers sensitivity to growth inhibition by the anti-CGRP antibody fremanezumab.

Tumor expression of CGRP confers sensitivity to growth inhibition by the anti-CGRP antibody fremanezumab.

Journal: European journal of pharmacology

Published: April 08, 2026

SARM1-dependent antimetabolic cancer therapy.

SARM1-dependent antimetabolic cancer therapy.

Journal: Cancer letters

Published: March 31, 2026

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis.

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis.

Journal: Cephalalgia : an international journal of headache

Published: November 28, 2025

Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia.

Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia.

Journal: Cephalalgia : an international journal of headache

Published: November 27, 2025

Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis.

Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis.

Journal: Journal of neuroimmunology

Published: July 23, 2025

New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice.

New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice.

Journal: Italian journal of pediatrics

Published: July 16, 2025

Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1.

Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1.

Journal: FEBS letters

Published: July 14, 2025

Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss.

Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss.

Journal: Pharmacological research

Published: April 02, 2025

Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation.

Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation.

Journal: The journal of pain

Published: February 27, 2025

Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception.

Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception.

Journal: Neurobiology of pain (Cambridge, Mass.)

Published: December 09, 2024

The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis.

The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis.

Journal: European journal of pharmacology

Published: November 25, 2024

Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis.

Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis.

Journal: Experimental neurology

Published: November 12, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026